Document Type
Blog Post
Publication Date
10-21-2024
Abstract
The Biden administration has conducted the government’s first ever negotiations with pharmaceutical companies on the cost of life saving drugs. They have been able to negotiate prices down by nearly 80%. The drugs at the center of negotiations are ones that people are prescribed for years at a time in order to manage illnesses such as heart disease, Crohn’s disease, and more. In order to conduct these negotiations, the Biden administration used march-in rights built into the Bayh-Dole Act.
The print edition of the issue has also been released. This post was originally published on the Cardozo Journal of Conflict Resolution website on October 21, 2024.
Recommended Citation
Anthony, Isabel, "The Biden Administration’s Negotiations With Pharmaceutical Companies" (2024). Cardozo Journal of Conflict Resolution (CJCR) Blog. 101.
https://larc.cardozo.yu.edu/cjcr-blog/101
